BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35258858)

  • 1. Landscape of T Cells in NK-AML(M4/M5) Revealed by Single-Cell Sequencing.
    Wu W; Liang X; Li H; Huang X; Wan C; Xie Q; Liu Z
    J Leukoc Biol; 2022 Oct; 112(4):745-758. PubMed ID: 35258858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of bone marrow heterogeneity in NK-AML (M4/M5) based on single-cell RNA sequencing.
    Wu W; Shi Z; Tang Z; Li H; Huang X; Liang X; Li J; Yao Y; Zhao W; Wu M; Luo J; Liu Z
    Exp Hematol Oncol; 2023 Mar; 12(1):25. PubMed ID: 36879313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia.
    Peng Q; Huang R; Wang H; Xiao H; Wang Y; Zhai Z; Wang Z
    Cancer Immunol Immunother; 2023 Dec; 72(12):4399-4414. PubMed ID: 37932426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.
    van Galen P; Hovestadt V; Wadsworth Ii MH; Hughes TK; Griffin GK; Battaglia S; Verga JA; Stephansky J; Pastika TJ; Lombardi Story J; Pinkus GS; Pozdnyakova O; Galinsky I; Stone RM; Graubert TA; Shalek AK; Aster JC; Lane AA; Bernstein BE
    Cell; 2019 Mar; 176(6):1265-1281.e24. PubMed ID: 30827681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
    Ferraro F; Miller CA; Christensen KA; Helton NM; O'Laughlin M; Fronick CC; Fulton RS; Kohlschmidt J; Eisfeld AK; Bloomfield CD; Ramakrishnan SM; Day RB; Wartman LD; Uy GL; Welch JS; Christopher MJ; Heath SE; Baty JD; Schuelke MJ; Payton JE; Spencer DH; Rettig MP; Link DC; Walter MJ; Westervelt P; DiPersio JF; Ley TJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA-seq reveals a microenvironment and an exhaustion state of T/NK cells in acute myeloid leukemia.
    Zhang Z; Deng C; Zhu P; Yao D; Shi J; Zeng T; Huang W; Huang Z; Wu Z; Li J; Xiao M; Fu L
    Cancer Sci; 2023 Oct; 114(10):3873-3883. PubMed ID: 37591615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering the cellular and omics characteristics of natural killer cells in the bone marrow microenvironment of patients with acute myeloid leukemia.
    Zhang L; Sun Y; Xue CE; Wang S; Xu X; Zheng C; Chen C; Kong D
    Cancer Cell Int; 2024 Mar; 24(1):106. PubMed ID: 38481242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia.
    Crinier A; Dumas PY; Escalière B; Piperoglou C; Gil L; Villacreces A; Vély F; Ivanovic Z; Milpied P; Narni-Mancinelli É; Vivier É
    Cell Mol Immunol; 2021 May; 18(5):1290-1304. PubMed ID: 33239726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy.
    Hu X; Cao D; Zhou Z; Wang Z; Zeng J; Hong WX
    Cell Oncol (Dordr); 2024 Feb; 47(1):97-112. PubMed ID: 37615858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
    Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Cianga VA; Campos Catafal L; Cianga P; Pavel Tanasa M; Cherry M; Collet P; Tavernier E; Guyotat D; Rusu C; Aanei CM
    Front Immunol; 2021; 12():665541. PubMed ID: 33986753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort.
    Herlin MK; Yones SA; Kjeldsen E; Holmfeldt L; Hasle H
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34064268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune receptor repertoires in pediatric and adult acute myeloid leukemia.
    Zhang J; Hu X; Wang J; Sahu AD; Cohen D; Song L; Ouyang Z; Fan J; Wang B; Fu J; Gu S; Sade-Feldman M; Hacohen N; Li W; Ying X; Li B; Liu XS
    Genome Med; 2019 Nov; 11(1):73. PubMed ID: 31771646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
    Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
    Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.
    Brück O; Dufva O; Hohtari H; Blom S; Turkki R; Ilander M; Kovanen P; Pallaud C; Ramos PM; Lähteenmäki H; Välimäki K; El Missiry M; Ribeiro A; Kallioniemi O; Porkka K; Pellinen T; Mustjoki S
    Blood Adv; 2020 Jan; 4(2):274-286. PubMed ID: 31968078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
    Corradi G; Bassani B; Simonetti G; Sangaletti S; Vadakekolathu J; Fontana MC; Pazzaglia M; Gulino A; Tripodo C; Cristiano G; Bandini L; Ottaviani E; Ocadlikova D; Piccioli M; Martinelli G; Colombo MP; Rutella S; Cavo M; Ciciarello M; Curti A
    Clin Cancer Res; 2022 Jul; 28(14):3141-3155. PubMed ID: 35349670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modular network structure of the mutational landscape of Acute Myeloid Leukemia.
    Ibáñez M; Carbonell-Caballero J; Such E; García-Alonso L; Liquori A; López-Pavía M; Llop M; Alonso C; Barragán E; Gómez-Seguí I; Neef A; Hervás D; Montesinos P; Sanz G; Sanz MA; Dopazo J; Cervera J
    PLoS One; 2018; 13(10):e0202926. PubMed ID: 30303964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggrephagy-related patterns in tumor microenvironment, prognosis, and immunotherapy for acute myeloid leukemia: a comprehensive single-cell RNA sequencing analysis.
    Pan Y; Wang Y; Hu M; Xu S; Jiang F; Han Y; Chen F; Liu Z
    Front Oncol; 2023; 13():1195392. PubMed ID: 37534253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.